Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis

American Journal of Kidney Diseases

Volumn 37, Issue 3, 2001, Pages 490-498

  Moroni, Gabriella ^a,f   Trendelenburg, Marten ^a,b,c,d,e   Del Papa, Nicoletta ^a,b,c,d,e   Quaglini, Silvana ^a,b,c,d,e   Raschi, Elena ^a,b,c,d,e   Panzeri, Paola ^a,b,c,d,e   Testoni, Cinzia ^a,b,c,d,e   Tincani, Angela ^a,b,c,d,e   Banfi, Giovanni ^a,b,c,d,e   Balestrieri, Genesio ^a,b,c,d,e   Schifferli, Jürg A ^a,b,c,d,e   Meroni, Pier Luigi ^a,b,c,d,e   Ponticelli, Claudio ^a,b,c,d,e  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SPEDALI CIVILI   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Immunologic tests; Renal involvement; Systemic lupus erythematosus (SLE)

Indexed keywords

CELL ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; RELIABILITY; REMISSION; SEROLOGY;

EID: 0035123526     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.22071     Document Type: Article

References (45)

1. The 1982 revised criteria for the classification of systemic lupus erythematosus
2. The role of antibodies to DNA in systemic lupus erythematosus. A review and introduction to an international workshop on DNA antibodies held in London
3. Immune complexes, complement and anti-DNA in exacerbation of systemic lupus erythematosus (SLE)
4. Measurement of increases in anti-double stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus
5. Significance of enzyme-linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: Correlation with severity of renal histology
6. Anti-DNA and complement profiles as prognostic guides in systemic lupus erythematosus
7. Systemic lupus with nephritis: A long-term study
8. Serologically active clinically quiescient systemic lupus erythematosus
9. IgM anti-DNA antibodies in systemic lupus erythematosus: Negative association with nephritis
10. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus
11. Lupus nephritis: The significance of serological tests at the time of biopsy
12. Anti-endothelial cell antibodies in systemic autoimmune diseases: Prevalence and clinical significance
13. Antibodies to endothelial cells in systemic lupus erythematosus: A potential marker for nephritis and vasculitis
14. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus
15. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus
16. Antibodies to C1q in systemic lupus erythematosus: Characteristics and relation to FcγRIIA alleles
17. Autoantibodies against C1q: View on clinical relevance and pathogenic roles
18. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients
19. Autoantibodies to the collagen-like region of C1q deposit in glomeruli via C1q in immune deposits
20. Stabilization of glomerular deposits of C1q by antibodies against C1q
21. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative glomerulonephritis
22. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus
23. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner
24. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro
25. Immunology of the antiphospholipid antibody syndrome
26. Endothelial cell binding by human polyclonal anti-DNA antibodies: Relationship to disease activity and endothelial functional alterations
27. Beta2-glycoprotein 1 as a "cofactor" for anti-phospholipid reactivity with endothelial cells
28. "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis
29. Flares in lupus nephritis: Incidence, impact on renal survival and management
30. Treatment of lupus nephritis: The advantages of a flexible approach
31. Treatment of membranous lupus nephritis
32. Derivation of the SLEDAI. A disease activity index for lupus patients
33. Anti-β2 glycoprotein 1 antibodies: A marker of anti-phospholipid syndrome
34. Relationship between anti-phospholipid and anti-endothelial cell antibodies: Further characterization of the reactivity on resting and cytokine-activated endothelial cells
35. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis
36. Lupus nephritis
37. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: Clinical and laboratory associations
38. Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjögren's syndrome and rheumatoid arthritis
39. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus
40. Serological markers of lupus nephritis in patients: Use of a tissue-based ELISA and evidence of immunopathogenic heterogeneity
41. Lupus nephritis: Association between serology and renal biopsy measures
42. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy
43. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus